Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PATENT ANALYSIS
4.1.1 MANUFACTURING PROCESS OF COMBINATION PRODUCTS
4.1.2 APPROVAL BY AGENCY
4.1.3 PATENT GRANT
4.1.4 PATENT CERTIFICATIONS:
5 PIPELINE ANALYSIS
6 REGULATORY FRAMEWORKS:
6.1 U.S.
6.2 CANADA
7 REGIONAL SUMMARY
7.1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
7.1.1 OVERVIEW
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
8.1.2 GROWING GERIATRIC POPULATION
8.1.3 ESCALATION IN INNOVATION AND TECHNOLOGIES
8.1.4 RISING RATES OF OBESITY
8.2 RESTRAINTS
8.2.1 PRODUCT RECALLS
8.2.2 RISK ASSOCIATED WITH THE COMBINATION PRODUCTS
8.3 OPPORTUNITIES
8.3.1 RISING EXPENDITURE ON HEALTHCARE
8.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
8.3.3 GROWING SUPPORT BY HEALTHCARE ORGANIZATIONS AND GOVERNMENT BODIES
8.3.4 INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
8.4 CHALLENGE
8.4.1 STRICT REGULATORY FRAMEWORK
9 IMPACT OF COVID-19 PANDEMIC ON THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON SUPPLY CHAIN
9.3 IMPACT ON DEMAND
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 AUTO-INJECTOR
10.2.1 WEARABLE AUTO-INJECTOR
10.2.2 HAND HELD AUTO-INJECTOR
10.3 MICRONEEDLE PATCH
10.4 DIGITAL PILL
10.5 SMART INHALER
10.6 DRUG DELIVERY HYDROGELS
10.7 DRUG-ELUTING LENS
10.8 OTHERS
11 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ORTHOPEDIC DISEASES
11.3 RESPIRATORY DISEASES
11.4 DIABETES
11.5 ONCOLOGY
11.6 CARDIOVASCULAR DISEASES
11.7 OTHERS
12 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER
12.1 OVERVIEW
12.2 CLINICS
12.3 HOSPITALS
12.4 HOME CARE SETTINGS
12.5 AMBULATORY CARE CENTERS
12.6 OTHERS
13 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAILS SALES
13.4 OTHERS
14 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 U.S.
14.2.2 CANADA
14.2.3 MEXICO
15 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY LANDSCAPE
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 AMGEN INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 GLAXOSMITHKLINE PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 MEDTRONIC
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 INSULET CORPORATION
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 BD
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 BAYER AG
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 EITAN MEDICAL
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 EOFLOW CO., LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 MEDIPRINT
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 MICRON BIOMEDICAL, INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 OCUMEDIC
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 OTSUKA AMERICA PHARMACEUTICAL, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 PROPELLER HEALTH
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 RAPHAS CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 SONCEBOZ
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 THERAJECT
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 VAXXAS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 ZIMMER BIOMET
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS
TABLE 2 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)
TABLE 7 U.S. DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 8 U.S. AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 9 U.S. DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 U.S. DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 11 U.S. DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 12 CANADA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 CANADA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 14 CANADA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 CANADA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 16 CANADA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 17 MEXICO DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 18 MEXICO AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 19 MEXICO DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 20 MEXICO DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 MEXICO DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: PRODUCT TYPE LIFELINE CURVE
FIGURE 8 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SEGMENTATION
FIGURE 13 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 THE AUTO-INJECTOR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DRUG-DEVICE COMBINATION MARKET IN THE YEAR 2021 & 2028
FIGURE 15 PORTER'S 5 FORCES
FIGURE 16 PESTEL'S MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: NORTH AMERICA DRUG-DEVICE COMBINATION MARKET
FIGURE 18 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE
FIGURE 19 AGEING POPULATION IN THE WORLD (IN MILLIONS)
FIGURE 20 NORTH AMERICA AGEING POPULATION (IN MILLION)
FIGURE 21 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES, 2016
FIGURE 22 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2020
FIGURE 23 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, 2019-2028 (USD MILLION)
FIGURE 24 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 25 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 26 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2020
FIGURE 27 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 28 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 29 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2020
FIGURE 31 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 32 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 33 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 36 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 37 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)
FIGURE 39 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)
FIGURE 40 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: BY PRODUCT (2021-2028)
FIGURE 43 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)
